Levobeta C Retard

Levodopa/Carbidopa, the active ingredient in Levobeta C Retard, is a dopamine precursor / dopa decarboxylase inhibitor combination presented as a modified‑release oral tablet for oral use. It is indicated for the management of Parkinson's disease and related motor symptoms in adults. GNH USA supplies Levobeta C Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levobeta C Retard is used within the Parkinson's disease therapeutic pathway to improve motor control and reduce fluctuations. - Parkinson's disease: improves overall motor function and reduces bradykinesia. - Resting tremor: diminishes tremor amplitude during periods of inactivity. - Motor fluctuations: smooths on‑off periods and prolongs the duration of clinical benefit.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: sensation of light‑headedness, especially on standing. - Headache: transient cranial discomfort. - Orthostatic hypotension: drop in blood pressure upon standing. - Insomnia: difficulty initiating or maintaining sleep. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements that may be disabling. - Hallucinations or psychosis: visual or auditory disturbances requiring medical review. - Severe hypotension: marked blood pressure decline leading to fainting. - Cardiac arrhythmias: irregular heart rhythms observed in susceptible patients.

Before initiating therapy, clinicians should assess individual risk factors and monitor patients regularly. - Titrate dose gradually: start low and increase to minimize gastrointestinal upset. - Monitor blood pressure: watch for orthostatic changes, especially in the elderly. - Evaluate hepatic and renal function: adjust dosing if impairment is present. - Avoid abrupt discontinuation: taper to prevent withdrawal symptoms. - Store at ambient temperature: keep in the original pack, protect from moisture.

Levobeta C Retard can interact with several drug classes; careful review is recommended.

Major Interactions (Avoid): - MAO‑B inhibitors: risk of hypertensive crisis when combined. - Antipsychotics (dopamine antagonists): may blunt therapeutic effect. - High‑dose pyridoxine (vitamin B6): accelerates peripheral levodopa metabolism. - Alpha‑adrenergic blockers: additive hypotensive effect.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: potential for serotonin syndrome. - Antihypertensive agents: may enhance blood pressure lowering. - Iron or calcium supplements: reduce levodopa absorption if taken simultaneously.